Status:
COMPLETED
An App-based Instructional Platform to Improve Eye Drop Recall
Lead Sponsor:
University of California, San Francisco
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop r...
Detailed Description
Specific Aim: To investigate whether a language-concordant instructional application improves drop regimen recall in population of glaucoma patients at a 1-month follow-up period. App features 1. Pi...
Eligibility Criteria
Inclusion
- patients with a diagnosis of glaucoma (any type)
- drop regimen of at least 2 pressure-lowering drops
- languages supported at this time: English, Spanish, Cantonese
Exclusion
- concurrent eye conditions necessitating additional eye drops
- inability to self-administer eye drops
- inability to engage with app (either visual or other barrier)
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06045390
Start Date
September 1 2024
End Date
June 1 2025
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco General Hospital
San Francisco, California, United States, 94110